Published in JAMA Psychiatry on December 01, 2014
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program. Am J Psychiatry (2015) 1.80
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry (2015) 1.10
A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. Schizophr Bull (2015) 1.01
Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program. Schizophr Bull (2016) 0.88
Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study. Transl Psychiatry (2015) 0.78
Etiology of cardiovascular disease in patients with schizophrenia: current perspectives. Neuropsychiatr Dis Treat (2015) 0.78
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study. Psychopharmacology (Berl) (2016) 0.78
Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span. Schizophr Bull (2016) 0.77
Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders. Schizophr Res (2015) 0.77
Associations between duration of untreated psychosis and domains of positive and negative symptoms. Early Interv Psychiatry (2015) 0.76
Brexpiprazole: so far so good. Ther Adv Psychopharmacol (2016) 0.76
Allele-Skewed DNA Modification in the Brain: Relevance to a Schizophrenia GWAS. Am J Hum Genet (2016) 0.76
Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls. Schizophr Res (2015) 0.76
Renal Denervation Improves the Baroreflex and GABA System in Chronic Kidney Disease-induced Hypertension. Sci Rep (2016) 0.75
Allostatic load and reduced cortical thickness in schizophrenia. Psychoneuroendocrinology (2016) 0.75
Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis. Ann Gen Psychiatry (2017) 0.75
Responses to Tobacco Smoking-Related Health Messages in Young People With Recent-Onset Schizophrenia. Schizophr Bull (2015) 0.75
The relationship between childhood trauma and adult psychosis in a UK Early Intervention Service: results of a retrospective case note study. Neuropsychiatr Dis Treat (2017) 0.75
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry (2017) 0.75
Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study. Neuropsychiatr Dis Treat (2017) 0.75
Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia? Front Neurosci (2017) 0.75
Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review. J Gen Intern Med (2016) 0.75
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurol Ther (2016) 0.75
Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record. Prim Care Companion CNS Disord (2016) 0.75
Systems Pharmacology Based Study of the Molecular Mechanism of SiNiSan Formula for Application in Nervous and Mental Diseases. Evid Based Complement Alternat Med (2016) 0.75
Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis. Transl Psychiatry (2016) 0.75
Effects of childhood and adolescence physical activity patterns on psychosis risk-a general population cohort study. NPJ Schizophr (2017) 0.75
CPA Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth. Can J Psychiatry (2017) 0.75
Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review. J Autism Dev Disord (2016) 0.75
Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia. Front Neurosci (2017) 0.75
Physical Health and Drug Safety in Individuals with Schizophrenia. Can J Psychiatry (2017) 0.75
Improving outcomes of first-episode psychosis: an overview. World Psychiatry (2017) 0.75
Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care. Early Interv Psychiatry (2017) 0.75
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry (2015) 1.15
Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry (2013) 1.06
Exercise practices in individuals at clinical high risk of developing psychosis. Early Interv Psychiatry (2013) 0.75
Effects of mental health benefits legislation: a community guide systematic review. Am J Prev Med (2015) 0.75
Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Interv Psychiatry (2017) 0.75
The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry (2017) 0.75